THE PROGNOSIS OF THE RESULTS OF DOUBLE-COMPONENT ANTIHYPERTENSIONAL THERAPY ACCOUNTING MEANINGS OF MIDDLE DAILY HEART RATE AND NON-MODIFIED RISK FACTORS
Abstract
In the grounds of complex examination of 300 patients with essential arterial hypertension the mathematical pattern of prognosis the results of double-component antihypertention therapy by enalaprili maleatum (10 mg per day) and hydrochlortiasidum (25 mg per day) was worked out. Accounted the initial meanings of middle daily heart rate (HR) non-modified risk factors (the blood pressure (BP) level, the type of somato-vagal balance and the type of left ventricular geometry). It was started, that good results of lowering BP in the double-component antihypertentional therapy by enalaprili maleatum (10 mg per day) and hydrochlortiasidum (25 mg per day) correspond the probabily of 70%, setisfed results of normalisation - the probabily of 50-70%, dissetistole results - the probabily of less then 50%. The double-component antihypertentional therapy by enalaprili maleatum (10 mg per day) and hydrochlortiasidum (25 mg per day) is shown to the patients with the probability of BP normalization more than 70%.
Downloads
References
2. Кобалава Ж.Д., Котовская Ю.В. Артериальная гипертония 2000. М.: Медицина, 2001. 198 с.
3. Свіщенко Е.П., Коваленко В.Н. Артериальная гипертензия. Практическое руководство. -К.: МОРІОН, 2001. 528 с.
4. Сіренко Ю. М. Артеріальна гіпертензія. 2002. 2-ге вид., доп. -К.: МОРІОН, 2002. 204 с.
5. Сіренко Ю.М., Рековець В.М., Гур’єва О.С. Артеріальна гіпертензія: сучасні аспекти контролю антигіпертензивної терапії (частина 2). // Український кардіологічний журнал. 2002. № 6. С.88-96.
6. Яблучанский Н.И., Исаева А. С., Мартыненко А. В. Основы практического применения неинва-зивной технологии исследования регуляторных систем человека. -Харьков: “Основа “. 2000. 88 с.
7. Agence Nationale d’Accreditation et d’Evaluation en Sante Recommandations (АNAES ), 2000. 117 p.
8. Chalmers J. // Clinical and Experimental Hypertension. 1999. Vol. 21. P. 875–884.
9. Guidelines Committee. 2003 European Society of Hypertension - European Society of Cardiology guide-lines for the management of arterial hypertension. // J. Hypertension. 2003. Vol. 21. P. 1011-1053.
10. Kalpan N.M. // Journal of Hypertension. 1999. Vol. 13. P. 707–710.
11. Korner I.P., Lennings C. // Journal of Hypertension. 1998. Vol. 16. P. 715-723.
12. Sica D.A., Ripley E. Low–Dose Fixed–Combination Antihypertensive Therapy in Hypertension a com-panion to the Brenner and Rectors’ The Kidney. Saunders Company. 2000. Р. 497–504.
The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
